CD4 and infection: In fact, a structurally modified scyllatoxin, a derived scorpion peptide, efficiently inhibited the binding of gp120 to CD4 in a competitive manner and thus suppressed the infection of CD4+ lymphocytes by human immunodeficiency viruses [100, 101].